IMA is loading

Main Financial Data 2004

Main Data: 31/12 Year 2004 
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 371.10
– gross margin 148.41
– total operating cost 111.06
– net operating profit 32.00
– financial expenses, net 4.18
– net income before taxes 13.30

 

Consolidated balance sheet Millions/Euro
– operating capital 75.12
– fixed assets, net 110.48
– reserves and MLT non financial payables – 17.51
– net financial position – 71.58
– stockholders’ equity 96.51

 

Other information Millions/Euro
– depreciation 15.86
– R & D expenses 17.35

 

  Euro
Dividend per share 0.40

 

  No.
Employees 2,480

 

  Euro
Share outstanding 18,772,000

 

Main Data: 30/06 Year 2004
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 150.48
– gross margin 61.63
– total operating cost 54.95
– net operating profit 4.13
– financial expenses, net 2.25
– net income before taxes 1.83

 

Consolidated balance sheet Millions/Euro
– operating capital 86.96
– fixed assets, net 100.81
– reserves and MLT non financial payables -14.32
– net financial position 87.53
– stockholders’ equity 85.92

 

Other information Millions/Euro
– depreciation 7.50
– R & D expenses 9.14

 

  No.
Employees 2,438

 

  Euro
Share outstanding 18,772,000

 

Net sales by sector: Year 2004
  Millions/Euro  
tea, herbs & coffee 65.69 17.70%
pharmaceuticals packaging 202.09 54.46%
pharmaceuticals processing 103.32 27.84%
Total 371.10 100.00%

 

Net sales by Country: Year 2004
  Millions/Euro  
E.U. (excluding Italy) 150.42 40.53%
Other European countries 26.06 7.02%
North America 75.13 20.25%
Asia & Middle East 54.42 14.66%
Other countries 34.36 9.26%
Total exports 340.39 91.72%
Italy 30.71 8.28%
Total 371.10 100.00%
Dismissclose

IMA Pharma
@ Achema

Explore the dedicated website and get a free entry pass with IMA